ClinicalTrials.Veeva

Menu

ALL Reconstruction Versus Modified Lemaire's LET in Combination With ACL Reconstruction With a Minimum Follow up of 2 Years (ARAVET)

Civil Hospices of Lyon logo

Civil Hospices of Lyon

Status

Enrolling

Conditions

Anterior Cruciate Ligament Injuries

Treatments

Procedure: ACL reconstruction with hamstrings combined with modified Lemaire's LET
Procedure: ACL reconstruction with hamstrings combined with ALL plasty

Study type

Interventional

Funder types

Other

Identifiers

NCT06147427
id-rcb (Other Identifier)
69HCL23_0851

Details and patient eligibility

About

Anterior cruciate ligament (ACL) tears are associated with concomitant lesions of the anterolateral ligament (ALL), which increase rotatory instability of the knee. If untreated, ALL insufficiency can compromise the results of ACL reconstruction, with higher risk of iterative ACL tear or additional meniscal lesion.

Several surgical techniques have been described to reconstruct the ALL. Indications are increasingly frequent and actually, consensus being young patients, patients practising pivot sports, significant rotational laxity on clinical examination with a positive pivot shift test, or in cases of iterative surgery. To date, the two most popular techniques are the Lemaire technique (use of a fascia lata strip) and LAL reconstruction plasty (use of part of an accessory hamstring tendon).

The older Lemaire procedure, popularized in the 1980s has proved its efficiency in terms of biomechanics, safety and reproducibility. More recently, following a new, precise anatomical description, anterolateral ligament plasty (ALL) has been developed, which is intended to be more anatomical than Lemaire's technique, but whose clinical superiority has not yet been demonstrated.

Both techniques are currently used in our department, with the choice of technique left to the surgeon's discretion.

To date, no randomized prospective study has demonstrated the clinical superiority of one technique over the other with a long term follow up.

The aim of this study was to compare graft survival of ALL reconstruction versus modified Lemaire LET in combination with ACL reconstruction with a minimum follow up of 2 years. Secondary aim was to compare functional outcomes between both groups.

Enrollment

248 estimated patients

Sex

All

Ages

18 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Man or woman with age between 18 and 50 years old
  • disabling anterior chronic laxity
  • 1 criteria of anterolateral plasty indication : pivot sport, rotatory instability with positive pivot shift test
  • Patient who signed the informed consent form.

Exclusion criteria

  • any associated procedure (excluding meniscal resection or repair) like osteotomy or meniscus graft
  • pregnant patient
  • Persons deprived of their liberty by judicial or administrative decision, persons under psychiatric care
  • Adults under legal protection

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

248 participants in 2 patient groups

ACL reconstruction with hamstrings combined with ALL plasty
Experimental group
Description:
Patient treated by ACL reconstruction with hamstrings combined anterolateral plasty using the ALL reconstruction technique (Gracilis throught the femur tunnel of the ACL graft and fixed to the tibia by an anchor on its point of isometry on the tibia).
Treatment:
Procedure: ACL reconstruction with hamstrings combined with ALL plasty
ACL reconstruction with hamstrings combined with modified Lemaire's LET
Experimental group
Description:
Patient treated by ACL reconstruction with hamstrings combined with modified Lemaire's lateral extra-articular tenodesis technique (Fascia lata strip pedicled to the Gerdy and fixed to the femur throught the tunnel of the ACL graft).
Treatment:
Procedure: ACL reconstruction with hamstrings combined with modified Lemaire's LET

Trial contacts and locations

1

Loading...

Central trial contact

Elvire SERVIEN, MD; Mahé RAFFIN

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems